PNET
MCID: SPR008
MIFTS: 42

Supratentorial Primitive Neuroectodermal Tumor (PNET) malady

Categories: Rare diseases, Cancer diseases, Neuronal diseases

Aliases & Classifications for Supratentorial Primitive Neuroectodermal Tumor

Aliases & Descriptions for Supratentorial Primitive Neuroectodermal Tumor:

Name: Supratentorial Primitive Neuroectodermal Tumor 12 50 14 69
Ewings Sarcoma-Primitive Neuroectodermal Tumor 69
Peripheral Neuroectodermal Tumor 50
Primative Neuroectodermal Tumor 50
Supratentorial Pnet 12
Pnet 50

Classifications:



External Ids:

Disease Ontology 12 DOID:4791
NCIt 47 C6968
SNOMED-CT 64 39781001 699318007
UMLS 69 C1336538

Summaries for Supratentorial Primitive Neuroectodermal Tumor

MalaCards based summary : Supratentorial Primitive Neuroectodermal Tumor, also known as ewings sarcoma-primitive neuroectodermal tumor, is related to pineoblastoma and supratentorial primitive neuroectodermal tumors, childhood, and has symptoms including fever An important gene associated with Supratentorial Primitive Neuroectodermal Tumor is SYP (Synaptophysin), and among its related pathways/superpathways are Neuroscience and Tyrosine metabolism. The drugs Afinitor and Sutent have been mentioned in the context of this disorder. Affiliated tissues include endothelial, breast and kidney, and related phenotype is behavior/neurological.

Related Diseases for Supratentorial Primitive Neuroectodermal Tumor

Diseases related to Supratentorial Primitive Neuroectodermal Tumor via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 86)
id Related Disease Score Top Affiliating Genes
1 pineoblastoma 30.0 IER3IP1 SYP
2 supratentorial primitive neuroectodermal tumors, childhood 12.2
3 malignant peripheral neuroectodermal tumor of cervix uteri 12.1
4 malignant peripheral neuroectodermal tumor of corpus uteri 12.0
5 atypical teratoid rhabdoid tumor 11.3
6 soft tissue peripheral neuroepithelioma 11.0
7 medulloblastoma 10.5
8 epidermal appendage tumor 10.2 SYP TH
9 jejunal neuroendocrine tumor 10.2 S100B SYP
10 microinvasive cervical squamous cell carcinoma 10.2 S100B SYP
11 corneal intraepithelial neoplasm 10.2 S100B SYP
12 adenofibroma 10.2 S100B SYP
13 methylmalonic aciduria and homocystinuria type cble 10.2 DDC SYP
14 behcet's syndrome arthropathy 10.2 S100B SYP
15 monkeypox 10.2 S100B SYP
16 aneurysm of sinus of valsalva 10.2 S100B SYP
17 early-onset parkinson disease 10.2 S100B SYP
18 bone deterioration disease 10.2 S100B SYP
19 lipoadenoma 10.2 RASSF1 SYP
20 clear cell ependymoma 10.2 RASSF1 S100B
21 hypogonadotropic hypogonadism-retinitis pigmentosa syndrome 10.2 S100B SYP
22 piussan lenaerts mathieu syndrome 10.2 S100B SYP
23 auricular cancer 10.2 S100B SYP
24 strabismus 10.2 S100B SYP
25 pediculus humanus corporis infestation 10.2 S100B SYP
26 non specific chronic endometritis 10.2 NCAM1 SYP
27 intrahepatic bile duct adenoma 10.2 NCAM1 SYP
28 tick-borne encephalitis 10.2 DDC TH
29 glomus tumor 10.2 NCAM1 SYP
30 spinal chordoma 10.2 NCAM1 SYP
31 ampulla of vater mucinous adenocarcinoma 10.2 S100B SYP
32 neuritis 10.2 NCAM1 SYP
33 ampullary signet ring cell adenocarcinoma 10.2 NCAM1 SYP
34 childhood brain germinoma 10.2 S100B SYP
35 main bronchus cancer 10.2 NCAM1 SYP
36 ovarian germ cell teratoma 10.2 NCAM1 SYP
37 inner ear cancer 10.2 S100B SYP
38 rectum leiomyoma 10.2 NCAM1 SYP
39 superior vena cava syndrome 10.1 NCAM1 SYP
40 pythiosis 10.1 DDC TH
41 fragile x-associated tremor/ataxia syndrome 10.1 NCAM1 SYP
42 anal squamous cell carcinoma 10.1 NCAM1 SYP
43 uterine corpus myxoid leiomyosarcoma 10.1 NCAM1 SYP
44 microsporidiosis 10.1 NCAM1 SYP
45 vulvar alveolar soft part sarcoma 10.1 NCAM1 SYP
46 trachea sarcoma 10.1 NCAM1 SYP
47 pathologic nystagmus 10.1 S100B SYP
48 pancreatic agenesis 10.1 NCAM1 SYP
49 central nervous system hemangioma 10.1 S100B SYP
50 myoepithelial carcinoma 10.1 NCAM1 SYP

Graphical network of the top 20 diseases related to Supratentorial Primitive Neuroectodermal Tumor:



Diseases related to Supratentorial Primitive Neuroectodermal Tumor

Symptoms & Phenotypes for Supratentorial Primitive Neuroectodermal Tumor

UMLS symptoms related to Supratentorial Primitive Neuroectodermal Tumor:


fever

MGI Mouse Phenotypes related to Supratentorial Primitive Neuroectodermal Tumor:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.1 SYP TH DDC NCAM1 S100B SLITRK6

Drugs & Therapeutics for Supratentorial Primitive Neuroectodermal Tumor

FDA approved drugs:

id Drug Name Active Ingredient(s) 17 Company Approval Date
1
Afinitor 17 46 EVEROLIMUS Novartis Approved March 2009
2
Sutent 17 46 SUNITINIB MALATE Pfizer Approved May 2011/ Approved January 2006

Drugs for Supratentorial Primitive Neuroectodermal Tumor (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 274)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754 657311
2
Prednisone Approved, Vet_approved Phase 4,Phase 2 53-03-2 5865
3
Dacarbazine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 4342-03-4 5351166
4
Temozolomide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 85622-93-1 5394
5
Somatostatin Approved Phase 4,Phase 1 38916-34-6, 51110-01-1 53481605
6
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
7 tannic acid Approved, Nutraceutical Phase 4
8
Butyric Acid Experimental Phase 4 107-92-6 264
9 Anesthetics Phase 4,Phase 3
10 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 1
11 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 1
12 Cortisol succinate Phase 4
13 glucocorticoids Phase 4,Phase 2,Phase 1
14 Hormone Antagonists Phase 4,Phase 2,Phase 1
15 Hormones Phase 4,Phase 2,Phase 1
16 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 1
17 Hydrocortisone 17-butyrate 21-propionate Phase 4
18 Hydrocortisone acetate Phase 4
19 Hydrocortisone-17-butyrate Phase 4
20 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1
22
Lactitol Phase 4 585-86-4 3871
23
Carboplatin Approved Phase 2, Phase 3, Phase 1 41575-94-4 10339178 498142 38904
24
Cyclophosphamide Approved, Investigational Phase 2, Phase 3, Phase 1 50-18-0, 6055-19-2 2907
25
Etoposide Approved Phase 2, Phase 3, Phase 1 33419-42-0 36462
26
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
27
Thiotepa Approved Phase 2, Phase 3, Phase 1 52-24-4 5453
28
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
29
Lenograstim Approved Phase 3,Phase 2,Phase 1 135968-09-1
30
Methotrexate Approved Phase 3,Phase 2 1959-05-2, 59-05-2 126941
31
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
32
Carmustine Approved Phase 3,Phase 2,Phase 1 154-93-8 2578
33
Trioxsalen Approved Phase 3,Phase 1 3902-71-4 5585
34
Lomustine Approved Phase 3,Phase 2 13010-47-4 3950
35
Levoleucovorin Approved Phase 3,Phase 2 68538-85-2
36
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
37
Donepezil Approved Phase 3 120014-06-4 3152
38
Procarbazine Approved Phase 3,Phase 2 671-16-9 4915
39
Isotretinoin Approved Phase 3,Phase 1 4759-48-2 5538 5282379
40
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
41
Ifosfamide Approved Phase 3,Phase 2,Phase 1 3778-73-2 3690
42
Mechlorethamine Approved Phase 3,Phase 2,Phase 1 51-75-2 4033
43
Topotecan Approved, Investigational Phase 3,Phase 2,Phase 1 119413-54-6, 123948-87-8 60700
44
Cyproheptadine Approved Phase 3,Phase 2 129-03-3 2913
45
Histamine Approved, Investigational Phase 3,Phase 2 75614-87-8, 51-45-6 774
46
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
47
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
48
Ondansetron Approved Phase 3 99614-02-5 4595
49
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
50
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 54575, 6560146 143

Interventional clinical trials:

(show top 50) (show all 196)
id Name Status NCT ID Phase
1 Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions Unknown status NCT02190994 Phase 4
2 Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients Recruiting NCT02520635 Phase 4
3 Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study. Recruiting NCT01794793 Phase 4
4 Post-approval Study of NovoTTF-100A in Recurrent GBM Patients Terminated NCT01756729 Phase 4
5 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
6 Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors Unknown status NCT00278239 Phase 3
7 Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors Unknown status NCT00392886 Phase 3
8 Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma Completed NCT00336024 Phase 3
9 Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal Tumor Completed NCT00006461 Phase 3
10 Surgery Plus Radiation Therapy With or Without Chemotherapy in Treating Children With Primitive Neuroectodermal Tumors of the CNS Completed NCT00003859 Phase 3
11 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
12 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3
13 Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme Completed NCT00002545 Phase 3
14 High Light and Low Light Dose PDT in Glioma Completed NCT00118222 Phase 3
15 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide Completed NCT00717210 Phase 3
16 Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children Completed NCT01635140 Phase 3
17 The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme Completed NCT00076986 Phase 3
18 Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma Recruiting NCT00392327 Phase 3
19 Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over Recruiting NCT02892708 Phase 3
20 Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma Recruiting NCT01096368 Phase 3
21 Prospective Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children Recruiting NCT01878266 Phase 3
22 Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Active, not recruiting NCT00085202 Phase 3
23 Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children Active, not recruiting NCT00749723 Phase 2, Phase 3
24 Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Active, not recruiting NCT01231906 Phase 3
25 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
26 Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy Active, not recruiting NCT01346267 Phase 3
27 Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy Active, not recruiting NCT00683319 Phase 3
28 Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Terminated NCT01132547 Phase 3
29 Radiation Therapy Followed By Combination Chemotherapy in Treating Young Patients With Supratentorial Primitive Neuroectodermal Tumors Unknown status NCT00274911 Phase 2
30 Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors Unknown status NCT00281905 Phase 2
31 Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma Unknown status NCT00283543 Phase 2
32 Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain Neoplasm Unknown status NCT00009854 Phase 1, Phase 2
33 Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma Unknown status NCT00826241 Phase 2
34 High-Dose Methotrexate in Treating Young Patients With Residual Ependymoma Unknown status NCT00287924 Phase 2
35 Etoposide in Treating Young Patients With Relapsed Ependymoma Unknown status NCT00278252 Phase 2
36 Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor Completed NCT00047177 Phase 2
37 Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma Completed NCT00006258 Phase 2
38 Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Completed NCT00003211 Phase 2
39 Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone Cancer Completed NCT00002466 Phase 2
40 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Completed NCT00025077 Phase 2
41 A Study of Pemetrexed in Children With Recurrent Cancer Completed NCT00520936 Phase 2
42 Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma Completed NCT00006102 Phase 2
43 A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma Completed NCT00668148 Phase 2
44 Combination Chemotherapy Plus Radiation Therapy in Treating Adult Patients With Brain Cancer Completed NCT00003309 Phase 2
45 Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma Completed NCT00070525 Phase 2
46 Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors Completed NCT00003203 Phase 2
47 Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Completed NCT00008008 Phase 2
48 Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors Completed NCT00003846 Phase 2
49 Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors Completed NCT00002463 Phase 2
50 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Completed NCT00005952 Phase 1, Phase 2

Search NIH Clinical Center for Supratentorial Primitive Neuroectodermal Tumor

Genetic Tests for Supratentorial Primitive Neuroectodermal Tumor

Anatomical Context for Supratentorial Primitive Neuroectodermal Tumor

MalaCards organs/tissues related to Supratentorial Primitive Neuroectodermal Tumor:

39
Endothelial, Breast, Kidney, T Cells, Pineal

Publications for Supratentorial Primitive Neuroectodermal Tumor

Articles related to Supratentorial Primitive Neuroectodermal Tumor:

(show all 49)
id Title Authors Year
1
Treatment outcome and patterns of failure in patients of non-pineal supratentorial primitive neuroectodermal tumor: review of literature and clinical experience form a regional cancer center in north India. ( 25990846 )
2015
2
Radiation-Induced Supratentorial Primitive Neuroectodermal Tumor after Treatment for Non-Hodgkin's Lymphoma. ( 26242031 )
2015
3
A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children. ( 24470556 )
2014
4
Supratentorial primitive neuroectodermal tumor presenting with intracranial hemorrhage in adult. ( 24966562 )
2014
5
MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system . ( 24470553 )
2014
6
A supratentorial primitive neuroectodermal tumor presenting with intracranial hemorrhage in a 42-year-old man: a case report and review of the literature. ( 23537064 )
2013
7
Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. ( 23790826 )
2013
8
Supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature. ( 23095172 )
2012
9
Supratentorial primitive neuroectodermal tumor (PNET): an uncommon location. ( 22297899 )
2011
10
Supratentorial primitive neuroectodermal tumors of the central nervous system in adults: molecular and histopathologic analysis of 12 cases. ( 21378543 )
2011
11
Severe allergic reactions to thiol-based cytoprotective agents mesna and amifostine in a child with a supratentorial primitive neuroectodermal tumor. ( 21646919 )
2011
12
Treatment of a supratentorial primitive neuroectodermal tumor using magnetic resonance-guided laser-induced thermal therapy. ( 22044371 )
2011
13
Late complete remission of supratentorial primitive neuroectodermal tumor (CNS-PNET) after multiple relapses. ( 21113945 )
2011
14
Successful radiation therapy for supratentorial primitive neuroectodermal tumor and epidermolysis bullosa simplex. ( 19760773 )
2010
15
Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas. ( 20515335 )
2010
16
Supratentorial primitive neuroectodermal tumor metastasis to the abdomen via a ventriculoperitoneal shunt. ( 20526591 )
2010
17
Reduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumor. ( 21120191 )
2010
18
Therapeutic Difficulty in a Case of Supratentorial Primitive Neuroectodermal Tumor Diagnosed during Pregnancy. ( 19242570 )
2009
19
Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children. ( 19411854 )
2009
20
Lipomatous supratentorial primitive neuroectodermal tumor with glioblastomatous differentiation. ( 19118780 )
2009
21
Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. ( 19434734 )
2009
22
A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature. ( 17713720 )
2008
23
[Different hypermethylation status of RASSF1A in medulloblastoma and supratentorial primitive neuroectodermal tumor]. ( 17374234 )
2007
24
Supratentorial primitive neuroectodermal tumor during pregnancy. Case report. ( 17505462 )
2007
25
High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. ( 17066462 )
2007
26
High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors. ( 16783165 )
2006
27
Long-term relapse-free survival with supratentorial primitive neuroectodermal tumor in an adult: a case report. ( 16528456 )
2006
28
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. ( 17016591 )
2006
29
Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. ( 16575007 )
2006
30
Supratentorial primitive neuroectodermal tumor (sPNET). ( 16612986 )
2006
31
Molecular genetics of supratentorial primitive neuroectodermal tumors and pineoblastoma. ( 16398467 )
2005
32
Secondary supratentorial primitive neuroectodermal tumor following irradiation in a patient with low-grade astrocytoma. ( 15661719 )
2005
33
Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor. ( 15712180 )
2005
34
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. ( 15719272 )
2005
35
Supratentorial primitive neuroectodermal tumor in an aged patient--case report--. ( 16247240 )
2005
36
Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging. ( 15131035 )
2004
37
[Supratentorial primitive neuroectodermal tumor: report of a surgical case]. ( 15352632 )
2004
38
Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. ( 15001261 )
2004
39
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor. ( 15310781 )
2004
40
PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors. ( 15547761 )
2004
41
Valproic acid induces differentiation of a supratentorial primitive neuroectodermal tumor. ( 15739631 )
2004
42
A novel case of a CAT to AAT transversion in codon 179 of the p53 gene in a supratentorial primitive neuroectodermal tumor harbored by a young girl. Case report and review of the literature. ( 12837982 )
2003
43
Unusual aberration involving the short arm of chromosome 11 in an 8-month-old patient with a supratentorial primitive neuroectodermal tumor. ( 12606132 )
2003
44
Mediastinal T-cell lymphoma in a boy 7 years after treatment of supratentorial primitive neuroectodermal tumor. ( 12902924 )
2003
45
Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. ( 11352962 )
2001
46
Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report. ( 11349224 )
2001
47
Supratentorial primitive neuroectodermal tumor in children: clinical features, treatment outcome and prognostic factors. ( 10447606 )
1999
48
A continuous cell line (KK-2) from a supratentorial primitive neuroectodermal tumor. ( 1323907 )
1992
49
Immunophenotype profile of childhood medulloblastomas and supratentorial primitive neuroectodermal tumors using 16 monoclonal antibodies. ( 2196109 )
1990

Variations for Supratentorial Primitive Neuroectodermal Tumor

Expression for Supratentorial Primitive Neuroectodermal Tumor

Search GEO for disease gene expression data for Supratentorial Primitive Neuroectodermal Tumor.

Pathways for Supratentorial Primitive Neuroectodermal Tumor

GO Terms for Supratentorial Primitive Neuroectodermal Tumor

Cellular components related to Supratentorial Primitive Neuroectodermal Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 terminal bouton GO:0043195 9.16 SYP TH
2 neuronal cell body GO:0043025 9.13 DDC S100B TH
3 synaptic vesicle GO:0008021 8.8 DDC SYP TH

Biological processes related to Supratentorial Primitive Neuroectodermal Tumor according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 cellular response to drug GO:0035690 9.51 DDC TH
2 memory GO:0007613 9.49 S100B TH
3 cellular response to growth factor stimulus GO:0071363 9.48 DDC TH
4 regulation of neuronal synaptic plasticity GO:0048168 9.46 S100B SYP
5 multicellular organism aging GO:0010259 9.43 DDC TH
6 cellular response to alkaloid GO:0071312 9.4 DDC TH
7 dopamine biosynthetic process GO:0042416 9.37 DDC TH
8 catecholamine biosynthetic process GO:0042423 9.32 DDC TH
9 response to pyrethroid GO:0046684 9.26 DDC TH
10 aminergic neurotransmitter loading into synaptic vesicle GO:0015842 9.16 DDC TH
11 isoquinoline alkaloid metabolic process GO:0033076 8.96 DDC TH
12 phytoalexin metabolic process GO:0052314 8.62 DDC TH

Molecular functions related to Supratentorial Primitive Neuroectodermal Tumor according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 amino acid binding GO:0016597 8.62 DDC TH

Sources for Supratentorial Primitive Neuroectodermal Tumor

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....